Biotechnology Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi May 2, 2022
Biotechnology Axsome Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update May 2, 2022
Biotechnology Axsome Therapeutics Receives FDA Complete Response Letter for New Drug Application for AXS-07 for the Acute Treatment of Migraine May 2, 2022
Biotechnology Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month May 2, 2022
Biotechnology Zymeworks Inc. (ZYME) Surges 23.2%: Is This an Indication of Further Gains? May 2, 2022
Biotechnology Ascendis Pharma A/S to Present New Endocrinology Results at Four Medical Meetings in May May 1, 2022